SCHEMBL140573

SCHEMBL140573

Nc1cccc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
HSD17B10 Q99714 2/20 0.65
ADORA2A P29274 2/20 0.48
PTPRC P08575 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HSPA1A P0DMV8 1/20 0.46
PABPC1 P11940 1/20 0.46
CSNK1A1 P48729 2/20 0.43
MAOA P21397 2/20 0.43
FGR P09769 1/20 0.43
PIM1 P11309 1/20 0.43
CSNK1D P48730 1/20 0.43
DYRK1A Q13627 1/20 0.43
HIPK2 Q9H2X6 1/20 0.43
CSNK1G1 Q9HCP0 1/20 0.43
DPP4 P27487 1/20 0.41
MAP4K4 O95819 1/20 0.41
CSF1R P07333 1/20 0.41
FGFR1 P11362 1/20 0.41
PDGFRA P16234 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1478478 0.98 ALDH1A1 (0.62) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
Ammonia Solution, Strong SCHEMBL28009585 0.98 ALDH1A1 (0.62) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
Ethylene SCHEMBL28845290 0.96 ALDH1A1 (0.60) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
SCHEMBL18045125 0.96 ALDH1A1 (0.60) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
Ethylene SCHEMBL27722615 0.94 ALDH1A1 (0.58) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
SCHEMBL8430179 0.92 ALDH1A1 (0.56) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
SCHEMBL29165707 0.91 ALDH1A1 (0.60) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
SCHEMBL24839924 0.88 ALDH1A1 (0.62) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
SCHEMBL27768614 0.88 ALDH1A1 (0.70) ALDH1A1HSD17B10ADORA2APTPRCL3MBTL1
SCHEMBL27626568 0.88 ALDH1A1 (0.52) ALDH1A1HSD17B10ADORA2AHPGDBCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 821 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4625518-A1 ELECTRODE PLATE FOR RECHARGEABLE LITHIUM BATTERY, AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2025-10-01 EP claimed
US-20250279432-A1 ELECTRODE PLATE FOR RECHARGEABLE LITHIUM BATTERY, AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2025-09-04 US claimed
CN-119798696-A Preparation method of bionic parallel vein-shaped two-dimensional supermolecular layer 西北工业大学 2025-04-11 CN claimed
CN-119504446-A One-pot method for preparing diphenyl aniline 西安近代化学研究所 2025-02-25 CN claimed
CN-113788783-B Self-reporting photosensitizer and preparation method and application thereof 江南大学 2023-08-22 CN claimed
US-20230123529-A1 METHOD OF TUNING THE ELECTRONIC ENERGY LEVEL OF COVALENT ORGANIC FRAMEWORK FOR CRAFTING HIGH-RATE NA-ION BATTERY ANODE INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) 2023-04-20 US claimed
WO-2021198868-A1 METHOD OF TUNING THE ELECTRONIC ENERGY LEVEL OF COVALENT ORGANIC FRAMEWORK FOR CRAFTING HIGH-RATE NA-ION BATTERY ANODE INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) 2021-10-07 WO claimed
CN-113307907-A Nonolactone polymer resin, preparation method thereof and preparation method of 193nm photoresist composition containing same 宁波南大光电材料有限公司 2021-08-27 CN claimed
CN-112876602-A Low-defect 193nm photoresist, photoresist resin and preparation method thereof 宁波南大光电材料有限公司 2021-06-01 CN claimed
CN-112764314-A Photoresist containing photoacid generator with diester structure and preparation method thereof 宁波南大光电材料有限公司 2021-05-07 CN claimed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US claimed
EP-1551412-B1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO NEUROTROPHINES MINERVA PATENTS SA (LU) 2011-05-04 EP claimed
EP-1205995-B1 Secondary battery of proton conductive polymer NEC TOKIN CORP (JP) 2008-09-24 EP claimed
US-7082027-B2 proton-conductive polymer; aqueous electrolytic solution of an organic or inorganic acid, and a imidazole, triazole, or pyrazole compound; to prevent the oxidation and degradation of electrode active materials, and to improve the cycle properties; NEC TOKIN CORPORATION (JP) 2006-07-25 US claimed
US-20060154176-A1 Photoresist composition, method of forming a photoresist pattern and method of forming a protection layer in a semiconductor device using the photoresist composition SAMSUNG ELECTRONICS CO., LTD. (KR) 2006-07-13 US claimed
WO-2005035121-A2 SCHIFF BASE METAL COMPLEXES FOR USE AS CATALYSTS IN ORGANIC SYNTHESIS UNIVERSITEIT GENT (BE) 2005-04-21 WO claimed
US-6800395-B2 CAPACITY CHARACTERISTIC AND CYCLE CHARACTERISTICS NEC TOKIN CORPORATION (JP) 2004-10-05 US claimed
US-20040110062-A1 Electrode using improved active material for battery and capacitor NEC TOKIN CORPORATION (JP) 2004-06-10 US claimed
US-20020086203-A1 Capacity characteristic and cycle characteristics NEC CORPORATION 2002-07-04 US claimed
EP-1205995-A2 Secondary battery of proton conductive polymer NEC CORPORATION (JP) 2002-05-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 ALDH1A1 486/4885HSD17B10 2413/4885ADORA2A 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.